Log in
SEARCH
All
News
CPD
CATEGORIES
Upcoming Events
Podcasts
On demand
Blood
Breast cancer
Cancer care
Childhood cancers
End-of-life care
Endocrine
GI cancer
GU cancer
Gynae cancer
Head and neck cancer
Lung cancer
Medicines
Medicopolitical
Melanoma
Podcasts
Radiation oncology
Research
Risk Factors
Sarcoma
About
About the limbic
Contact
Website Disclaimer
Privacy Policy
Terms & Conditions
news
cpd
Search
All
News
CPD
Account
Saved
SEARCH
All
News
CPD
CATEGORIES
Blood
Breast cancer
Cancer care
Childhood cancers
End-of-life care
Endocrine
GI cancer
GU cancer
Gynae cancer
Head and neck cancer
Lung cancer
Medicines
Medicopolitical
Melanoma
Podcasts
Radiation oncology
Research
Risk Factors
Sarcoma
Events
Podcasts
On demand
Log out
‘Landmark’ survival benefit for adjuvant immunotherapy in RCC
GU cancer
New cancer research centre announced for QIMR Berghofer
Research
ACE-inhibitor fails to prevent anthracycline cardiotoxicity
Medicines
After 20 years, eviQ cancer guidance gains global acceptance
Cancer care
‘Digital energy coach’ promoted for cancer-related fatigue
Cancer care
Why the pathology bulk-billing campaign is more about driving industry profits than saving you money
Financial
MORE NEWS
Pharma funding: which specialties accept the most payments?
Financial
Call to count ‘abandoned’ metastatic breast cancer patients
Breast cancer
Chemotherapy avoidance confirmed in NSCLC patients
Lung cancer
‘Highly meaningful’ benefit with adjuvant alectinib in NSCLC
Lung cancer
Pharmacogenomic testing guidance to prevent adverse events
Medicines
Special report: leadership chaos strikes the RACP
Medical politics
Positive signal of early stage shift in CRC diagnoses
GI cancer
Why medical indemnity is back on the agenda
Financial
Healthcare private equity acquisitions on the rise in Australia
Financial
Institute launches cultural probe amid sexual harassment claims
sexism
Pandemic-related excess CRC deaths can still be averted: study
GI cancer
PBS listing for cemiplimab in metastatic NSCLC
Lung cancer
more news